Were the Cinemark (CNK) share transfers sales for cash?

No. The filing states that the transfers of 34,105 shares, 16,273 shares, and 7,364 shares to the revocable family trust were made for no consideration , indicating they were not sales for cash.

How is the Cinemark (CNK) director related to the family trust?

The filing explains that the director is a trustee of the revocable family trust that received the transferred shares, which is why the trust-held shares are reported as beneficially owned.

Cinemark (NYSE: CNK) director moves shares to family trust and gets award

Q: How many Cinemark (CNK) shares were transferred to the family trust?

The director transferred 34,105 shares on 07/11/2022, 16,273 shares on 07/05/2024, and 7,364 shares on 07/17/2025 to a revocable family trust for which the director is trustee.

Q: What stock award did the Cinemark (CNK) director receive?

On 06/15/2023 , the director received an annual award of 7,867 restricted shares of Cinemark common stock, granted under the director compensation policy with a par value of $0.01 per share.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Cinemark Holdings, Inc. disclosed that one of its directors reported several transactions in the company’s common stock. On 07/11/2022, the director transferred, for no consideration, 34,105 shares to a revocable family trust for which the director serves as trustee. On 06/15/2023, the director received an annual award of 7,867 restricted shares under the director compensation policy, with a par value of $0.01 per share.

On 07/05/2024, the director transferred, again for no consideration, 16,273 shares to the same revocable family trust, and on 07/17/2025 transferred a further 7,364 shares to that trust, also for no consideration. Following the latest transaction, the director beneficially owned 4,200 shares directly and 57,742 shares indirectly through the family trust.

Insider Trade Summary

57,742 shares gifted

Mixed 4 txns

Insider Syufy Raymond W

Role Director

Type	Security	Shares	Price	Value
Gift	Common Stock	7,364	$0.00	--
Gift	Common Stock	16,273	$0.00	--
Grant/Award	Common Stock	7,867	$0.00	--
Gift	Common Stock	34,105	$0.00	--

Holdings After Transaction: Common Stock — 57,742 shares (Indirect, By Family Trust); Common Stock — 16,273 shares (Direct)

Footnotes (1)

On 7/11/2022 the reporting person transferred, for no consideration, 34,105 shares of the common stock of issuer to a revocable family trust for which this person is a trustee. Annual award of restricted stock pursuant to the director compensation policy. Par value is $0.01 per share. On 07/05/2024 the reporting person transferred, for no consideration, 16,273 shares of the common stock of issuer to a revocable family trust for which this person is a trustee. On 7/17/2025 the reporting person transferred, for no consideration, 7,364 shares of the common stock of issuer to a revocable family trust for which this person is a trustee. Following such transaction, the reporting person beneficially owned 4,200 shares of common stock of the issuer directly and beneficially owned 57,742 shares of common stock of the issuer indirectly through a family trust for which the reporting person is a trustee.

Form 4 Insider Transactions: What Each Field Means →

12/22/2025 - 06:55 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Syufy Raymond W

(Last)

(First)

(Middle)

3900 DALLAS PKWY

(Street)

PLANO

75093

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Cinemark Holdings, Inc. [ CNK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/11/2022

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/11/2022		G		34,105⁽¹⁾	A	$0	34,105	I	By Family Trust
Common Stock	06/15/2023		A		7,867	A	$0⁽²⁾	16,273	D
Common Stock	07/05/2024		G		16,273⁽³⁾	A	$0	50,378	I	By Family Trust
Common Stock	07/17/2025		G		7,364⁽⁴⁾	A	$0	57,742	I	By Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On 7/11/2022 the reporting person transferred, for no consideration, 34,105 shares of the common stock of issuer to a revocable family trust for which this person is a trustee.

2. Annual award of restricted stock pursuant to the director compensation policy. Par value is $0.01 per share.

3. On 07/05/2024 the reporting person transferred, for no consideration, 16,273 shares of the common stock of issuer to a revocable family trust for which this person is a trustee.

4. On 7/17/2025 the reporting person transferred, for no consideration, 7,364 shares of the common stock of issuer to a revocable family trust for which this person is a trustee. Following such transaction, the reporting person beneficially owned 4,200 shares of common stock of the issuer directly and beneficially owned 57,742 shares of common stock of the issuer indirectly through a family trust for which the reporting person is a trustee.

	/s/ Michael Cavalier, attorney-in-fact	12/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Cinemark (CNK) disclose in this Form 4?

The filing shows a Cinemark director reported multiple transfers of common stock to a revocable family trust for no consideration, plus an annual restricted stock award under the director compensation policy.

How many Cinemark (CNK) shares were transferred to the family trust?

The director transferred 34,105 shares on 07/11/2022, 16,273 shares on 07/05/2024, and 7,364 shares on 07/17/2025 to a revocable family trust for which the director is trustee.

What stock award did the Cinemark (CNK) director receive?

On 06/15/2023, the director received an annual award of 7,867 restricted shares of Cinemark common stock, granted under the director compensation policy with a par value of $0.01 per share.

What is the director’s beneficial ownership in Cinemark (CNK) after these transactions?

After the 07/17/2025 transfer, the director beneficially owned 4,200 shares of Cinemark common stock directly and 57,742 shares indirectly through the revocable family trust.